CompoAtlas

COMPLEXE MITO ReCOVery*

Food supplement declared in France

COMPLEXE MITO ReCOVery* is a food supplement declared in France. Status: retrait du marché annoncé pour le 18 February 2028. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
Sunday Natural Products GmbH
Status
Retrait du marché annoncé pour le 18 February 2028
Form
Gélule
Daily dose
9,1 g
Intended populations
Population générale
Not recommended for (according to the manufacturer)
Enfants en bas âge (1 à 3 ans), Nourrissons (moins de 1 an), Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)

Declaration 363743, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Substances

NamePer day
ribose2,400 mg
taurine300 mg
acétylcystéine300 mg
Galactose60 mg

Other active ingredients

NamePer day
L-Arginine-alpha-cétoglutaratenot declared
Chlorhydrate d'acétyl-L-carnitinenot declared
Créatine monohydratenot declared
L-Carnitine L-Tartratenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Citrate-malate de magnésiumMagnésium250 mg300 mg
Malate de magnésiumMagnésium250 mg300 mg
L-ascorbate de magnésiumVitamine Cpas de limite (données insuffisantes)180 mg

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line